LEADER 03597nam 22009613u 450 001 996339117803316 005 20221205203635.0 010 $a1-280-75122-3 010 $a9786610751228 010 $a1-84692-564-9 035 $a(CKB)1000000000555236 035 $a(EBL)362687 035 $a(OCoLC)476193569 035 $a(SSID)ssj0000106919 035 $a(PQKBManifestationID)11984396 035 $a(PQKBTitleCode)TC0000106919 035 $a(PQKBWorkID)10013323 035 $a(PQKB)11303127 035 $a(Au-PeEL)EBL362687 035 $a(CaONFJC)MIL75122 035 $a(MiAaPQ)54796 035 $a(EXLCZ)991000000000555236 100 $a20130418d2007|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAsthma$b[electronic resource] $eModern Therapeutic Targets 210 $aOxford $cAtlas Medical Publishing Ltd$d2007 215 $a1 online resource (205 p.) 225 1 $aTherapeutic Strategies 300 $aDescription based upon print version of record. 311 $a1-904392-70-9 327 $aContents; Editors and Contributors; Preface; Section I: Autocoids and their receptors in airway diseases; Section II: Enzyme inhibitors; Section III: Sensory nerves and sensory neuropeptides; Section IV: Receptors in immunology; Abbreviations; Index 330 $aThe care of an increasing number of adult and child patients with asthma has become a major task for clinicians, and a growing concern for public health physicians and health care administrators. At the same time, and in response to this situation, a considerable effort is being made in basic and clinical research to develop new treatments. This book looks into the future and assesses the possibilities of a number of new therapies for asthma under exploration and development. A group of distinguished international authors examine the potential of new agents working on various targets that are 410 0$aTherapeutic Strategies 606 $aAnti-inflammatory agents 606 $aAsthma -- Treatment 606 $aAsthma 606 $aRespiratory Hypersensitivity 606 $aLung Diseases, Obstructive 606 $aRespiratory System Agents 606 $aBronchial Diseases 606 $aRespiratory Tract Diseases 606 $aTherapeutic Uses 606 $aLung Diseases 606 $aHypersensitivity, Immediate 606 $aDiseases 606 $aHypersensitivity 606 $aPharmacologic Actions 606 $aChemical Actions and Uses 606 $aImmune System Diseases 606 $aAsthma 606 $aAnti-Asthmatic Agents 615 4$aAnti-inflammatory agents. 615 4$aAsthma -- Treatment. 615 4$aAsthma. 615 2$aRespiratory Hypersensitivity 615 2$aLung Diseases, Obstructive 615 2$aRespiratory System Agents 615 2$aBronchial Diseases 615 2$aRespiratory Tract Diseases 615 2$aTherapeutic Uses 615 2$aLung Diseases 615 2$aHypersensitivity, Immediate 615 2$aDiseases 615 2$aHypersensitivity 615 2$aPharmacologic Actions 615 2$aChemical Actions and Uses 615 2$aImmune System Diseases 615 2$aAsthma 615 2$aAnti-Asthmatic Agents 676 $a616.2/38061 700 $aPolosa$b Riccardo$01008374 701 $aHolgate$b S. T$0878514 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a996339117803316 996 $aAsthma$92325676 997 $aUNISA